SLCO1B1 and coronary artery disorder: Carriers of SLCO1B1*37 had reduced CHD risk versus non-carriers (HR: 0.94, 95%CI: 0.89 to 0.99, p = 0.02) (rates: 21.8% versus 23.1%, respectively).